1 paper
Ziyu Su, Yongxin Guo, Robert Wesolowski +4
Accurate recurrence risk stratification is crucial for optimizing treatment plans for breast cancer patients. Current prognostic tools like Oncotype DX (ODX) offer valuable genomic…